ada guidelines glp 1 for Diabetes 2026 #ada #diabetes @dr_samia_asim Standards of Medical Care in
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 127.Hamamah S., Amin A., Al-Kassir A.L., Chuang J., Covasa M
Medical supervision to ensure safe, effective treatment
The number of participants using sodium-glucose cotransporter-2 (SGLT2) inhibitors was low at baseline (15%), but that number increased during the trial
30 However, in 80% of the patients who experienced worsening, DR improved despite continued treatment with GLP-1RA, implying a temporary effect
When GLP-1 receptor agonists are combined with insulin or sulfonylureas, the doses of these medications may need to be reduced to avoid hypoglycemia
20% reduction in major cardiovascular events and 19% lower all-cause death in obesity without diabetes
